Dr. Garrett is an associate professor at Boston-based Harvard School of Medicine. Her research focuses on the interplay between the gastrointestinal immune system, gut microbiota, inflammatory bowel disease and colorectal cancer.
uBiome is a microbial genomics company. Its SmartGut is the first sequencing-based clinical microbiome test designed to identify gut microbes for patients with IBD, irritable bowel syndrome, Crohn’s disease and ulcerative colitis.
More articles on gastroenterology:
3 possible regulatory changes in GI that ASGE supports
Which states have the highest screening rates for CRC? 4 takeaways
5 must-read stories for GI physicians this week: November 22-28
